Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 | Research

Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department

Authors: Faysal Subhani, Abdul Ahad Chhotani, Shahan Waheed, Rana Osama Zahid, Kiran Azizi, Ahmed Raheem Buksh

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Critically-ill Covid-19 patients require extensive resources which can overburden a healthcare system already under strain due to a pandemic. A good disease severity prediction score can help allocate resources to where they are needed most.

Objectives

We developed a Covid-19 Severity Assessment Score (CoSAS) to predict those patients likely to suffer from mortalities within 28 days of hospital admission. We also compared this score to Quick Sequential Organ Failure Assessment (qSOFA) in adults.

Methods

CoSAS includes the following 10 components: Age, gender, Clinical Frailty Score, number of comorbidities, Ferritin level, D-dimer level, neutrophil/lymphocyte ratio, C-reactive Protein levels, systolic blood pressure and oxygen saturation. Our study was a single center study with data collected via chart review and phone calls. 309 patients were included in the study.

Results

CoSAS proved to be a good score to predict Covid-19 mortality with an Area under the Curve (AUC) of 0.78. It also proved better than qSOFA (AUC of 0.70). More studies are needed to externally validate CoSAS.

Conclusion

CoSAS is an accurate score to predict Covid-19 mortality in the Pakistani population.
Literature
1.
go back to reference Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26(4):506–10.CrossRef Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26(4):506–10.CrossRef
3.
go back to reference Dat VQ, Long NT, Hieu VN, Phuc NDH, Van KN, Trung NV, et al. Clinical characteristics, organ failure, inflammatory markers and prediction of mortality in patients with community acquired bloodstream infection. BMC Infect Dis. 2018;18(1):1–8.CrossRef Dat VQ, Long NT, Hieu VN, Phuc NDH, Van KN, Trung NV, et al. Clinical characteristics, organ failure, inflammatory markers and prediction of mortality in patients with community acquired bloodstream infection. BMC Infect Dis. 2018;18(1):1–8.CrossRef
5.
go back to reference Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;9(370):22. Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;9(370):22.
6.
go back to reference Moreno-Pérez Ó, Andrés M, León-Ramirez JM, Sánchez-Payá J, Boix V, Gil J, et al. The COVID-GRAM tool for patients hospitalized with COVID-19 in Europe. JAMA Intern Med. 2021;181(7):1000–1.CrossRef Moreno-Pérez Ó, Andrés M, León-Ramirez JM, Sánchez-Payá J, Boix V, Gil J, et al. The COVID-GRAM tool for patients hospitalized with COVID-19 in Europe. JAMA Intern Med. 2021;181(7):1000–1.CrossRef
7.
go back to reference Satici C, Demirkol MA, SarginAltunok E, Gursoy B, Alkan M, Kamat S, et al. Performance of pneumonia severity index and CURB-65 in predicting 30 day mortality in patients with COVID-19. Int J Infect Dis. 2020;98:84–9.CrossRef Satici C, Demirkol MA, SarginAltunok E, Gursoy B, Alkan M, Kamat S, et al. Performance of pneumonia severity index and CURB-65 in predicting 30 day mortality in patients with COVID-19. Int J Infect Dis. 2020;98:84–9.CrossRef
8.
go back to reference Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–6.PubMed Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–6.PubMed
9.
go back to reference Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–6.CrossRef Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–6.CrossRef
10.
go back to reference Liu S, Yao N, Qiu Y, He C. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. Am J Emerg Med. 2020;38(10):2074–80.CrossRef Liu S, Yao N, Qiu Y, He C. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. Am J Emerg Med. 2020;38(10):2074–80.CrossRef
11.
go back to reference Hajian-Tilaki K. The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation. Stat Methods Med Res. 2018;27(8):2374–83.CrossRef Hajian-Tilaki K. The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation. Stat Methods Med Res. 2018;27(8):2374–83.CrossRef
13.
go back to reference Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):640.CrossRef Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):640.CrossRef
14.
go back to reference Nickel CH, Rueegg M, Pargger H, Bingisser R. Age, comorbidity, frailty status: effects on disposition and resource allocation during the COVID-19 pandemic. Swiss Med Wkly. 2020;20(150): w20269. Nickel CH, Rueegg M, Pargger H, Bingisser R. Age, comorbidity, frailty status: effects on disposition and resource allocation during the COVID-19 pandemic. Swiss Med Wkly. 2020;20(150): w20269.
15.
go back to reference Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–8.CrossRef Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–8.CrossRef
16.
go back to reference Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395(10229):1054–62.CrossRef Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395(10229):1054–62.CrossRef
17.
go back to reference Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55–63.CrossRef Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55–63.CrossRef
18.
go back to reference Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10.CrossRef Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10.CrossRef
19.
go back to reference Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region. Italy Jama. 2020;323(16):1574–81.CrossRef Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region. Italy Jama. 2020;323(16):1574–81.CrossRef
21.
go back to reference Maddox TM, Stecker EC, Bozkurt B, DeMichelis N, Doherty JU, Freeman A, Gluckman TJ, Itchhaporia D, Miller AP, Price AL, Reisman L. COVID-19 clinical guidance for the cardiovascular care team. Am College Cardiol. 2020. Maddox TM, Stecker EC, Bozkurt B, DeMichelis N, Doherty JU, Freeman A, Gluckman TJ, Itchhaporia D, Miller AP, Price AL, Reisman L. COVID-19 clinical guidance for the cardiovascular care team. Am College Cardiol. 2020.
23.
go back to reference Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;1(108): 154262.CrossRef Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;1(108): 154262.CrossRef
24.
go back to reference Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.CrossRef Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.CrossRef
25.
go back to reference Javed M, Qureshi MA, Akhtar MN, Ullah S, Habib O, Saqib M. Correlation of qSOFA with severity of COVID-19 infection assessed on admission at tertiary care hospital in Lahore. Turk J Emerg Med. 2018;35(1):1–6.CrossRef Javed M, Qureshi MA, Akhtar MN, Ullah S, Habib O, Saqib M. Correlation of qSOFA with severity of COVID-19 infection assessed on admission at tertiary care hospital in Lahore. Turk J Emerg Med. 2018;35(1):1–6.CrossRef
27.
go back to reference Bradley P, Frost F, Tharmaratnam K, Wootton DG. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open Respir Res. 2020;7(1): e000729.CrossRef Bradley P, Frost F, Tharmaratnam K, Wootton DG. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open Respir Res. 2020;7(1): e000729.CrossRef
28.
go back to reference Rivera-Izquierdo M, del Carmen V-U, R-delAmo JL, Fernandez-Garcia MA, Martinez-Diz S, Tahery-Mahmoud A, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: a retrospective observational study. PLoS ONE. 2020;15(6): e0235107.CrossRef Rivera-Izquierdo M, del Carmen V-U, R-delAmo JL, Fernandez-Garcia MA, Martinez-Diz S, Tahery-Mahmoud A, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: a retrospective observational study. PLoS ONE. 2020;15(6): e0235107.CrossRef
29.
go back to reference Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–47.CrossRef Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–47.CrossRef
30.
go back to reference Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Wiley Online Lib. 2020;18(6):1324–9. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Wiley Online Lib. 2020;18(6):1324–9.
31.
go back to reference Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis. 2020;71(6):1393–9.CrossRef Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis. 2020;71(6):1393–9.CrossRef
33.
go back to reference Haimovich AD, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, Schulz WL, Taylor RA. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76(4):442–53.CrossRef Haimovich AD, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, Schulz WL, Taylor RA. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76(4):442–53.CrossRef
Metadata
Title
Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department
Authors
Faysal Subhani
Abdul Ahad Chhotani
Shahan Waheed
Rana Osama Zahid
Kiran Azizi
Ahmed Raheem Buksh
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07535-8

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue